ArticleMalaria journal2019
Bio-efficacy and physical integrity of piperonylbutoxide coated combination net (PermaNet
Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 14 citations in OpenAlex.
- Physical integrity and bioefficacy of long-lasting insecticidal nets 18 months after use among Central African Republic refugees in Gado-Badzere, a high malaria burden camp in Cameroon.Parasite epidemiology and control · 2026Article
- Effectiveness of Pyrethroid-Piperonyl Butoxide Nets Versus Standard Pyrethroid-Only Nets in Preventing Malaria in Children Under 10 Years Living in Kisantu Health Zone, Democratic Republic of the Congo.Tropical medicine and infectious disease · 2025Article
- Durability of PBO nets (Olyset Plus®), 12 months after their distribution in Bertoua, Cameroon.Parasite epidemiology and control · 2024Article
- Physical integrity and bioefficacy of used long-lasting insecticidal nets in Makenene, Centre Region of Cameroon.Journal of medical entomology · 2024Article
- High efficacy of chlorfenapyr-based net InterceptorInfectious diseases of poverty · 2023Article
- Multi-country evaluation of the durability of pyrethroid plus piperonyl-butoxide insecticide-treated nets: study protocol.Malaria journal · 2023Article
- Understanding the current state-of-the-art of long-lasting insecticide nets and potential for sustainable alternatives.Current research in parasitology & vector-borne diseases · 2022Review
- A whole transcriptomic approach provides novel insights into the molecular basis of organophosphate and pyrethroid resistance in Anopheles arabiensis from Ethiopia.Insect biochemistry and molecular biology · 2021Article
- Malaria prevention practices and associated factors among households of Hawassa City Administration, Southern Ethiopia, 2020.PloS one · 2021Article
- Anopheles metabolic proteins in malaria transmission, prevention and control: a review.Parasites & vectors · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPermaNet
methodsInsecticide susceptibility test was conducted using the WHO tube test. Bio-activity of PermaNet
resultsBoth Anopheles gambiae sensu lato and Culex quinquefasciatus developed resistance against permethrin and deltamethrin. However, following pre-exposure to synergist PBO the susceptibility of mosquito population increased to both permethrin (from 39% without to 92% with PBO against An. gambiae and from 28% without to 94% with PBO against Culex quinquefasciatus) and deltamethrin (from 52% without to 99% with PBO against An. gambiae and from 43% without to 98% with PBO against Culex quinquefasciatus). Eighty percent (80%) mortality was recorded in wild population of An. gambiae s.l. exposed to unused PermaNet
conclusionsThe bio-efficacy evaluation of PermaNet
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.